NCT04728633View on ClinicalTrials.gov

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 27, 2021

Primary Completion Date

January 31, 2027

Study Completion Date

June 30, 2027

Conditions
Metastatic Malignant Neoplasm in the LiverMetastatic Uveal MelanomaStage IV Choroidal and Ciliary Body Melanoma AJCC V8
Interventions
DRUG

Carmustine

Given via infusion

DRUG

Ethiodized Oil

Given via infusion

PROCEDURE

Transarterial Chemoembolization

Undergo TACE

OTHER

Medical Device Usage and Evaluation

Given gelatin sponge via injection

Trial Locations (1)

19107

Sidney Kimmel Cancer Center at Thomas Jefferson Univeristy, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER